Silver Book Fact

According to the Pharmaceutical Research and Manufacturers of America, researchers are currently working on 646 medicines for cancer. All are either in clinical trials or under FDA review. They include 96 for lung cancer, 79 for breast cancer, 66 for colorectal cancer, and 79 for prostate cancer. Other medicines target brain, kidney, ovarian, pancreatic, skin, and other cancers. Companies are also working on medicines to improve quality of life for those with cancer.

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, a radiopharmaceutical currently in development is a synthetic version of a substance derived from scorpions–chlorotoxin. This could be a powerful…  
  • The standard treatment for prostate cancer used to require radical prostatectomy. Now, less invasive therapies like brachytherapy have been shown to have equal outcomes with fewer side effects.  
  • Since 1975, the five year survival rate for breast cancer patients has increased by 40 percent.  
  • After one year, 73 percent of non-small-cell lung cancer patients with the EGFR genetic mutation who were treated with a tyrosine kinase inhibitor had survived, compared to 15 percent who…  
  • 750 cancer-fighting medicines are currently in development.